Dr. Arthur H Rossof MD

Each year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...

Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...

A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...

Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...

Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...